FDA Inspection
Dallas IVFDallas IVF – FDA Inspection, Dec 9, 2019
Record Details
This FDA Inspection record concerns Dallas IVF, with an inspection on December 9, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Dallas IVF
- Inspection Date
- December 9, 2019
- Product Type
- Biologics
View Company Profile
ID · eeb2b06c-8461-463b-989b-0940d7e41c27
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1112244
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.85(b)(2)SOP for release; reactive for CMV
- 21 CFR 1271.270(a)Records incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dallas IVF
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 11, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 7, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 17, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Dallas IVF
- FDA Inspection 1234907 - 2024-03-28
- FDA Inspection 1020991 - 2017-07-11
- FDA Inspection 817417 - 2013-02-07
- FDA Inspection 667829 - 2010-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.